USFDA approves intramuscular administration for Merck’s MMRV family of vaccines
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
This sBLA submission is supported by clinical, pre-clinical, and manufacturing data demonstrating the safety, tolerability, and immunogenicity of the bivalent vaccine.
Submissions based on favorable MagnetisMM-3 trial results in patients with relapsed or refractory multiple myeloma
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
Data build on previously reported results from the primary endpoint of investigator-assessed radiographic progression-free survival
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5%
Zidavi is recommended by the Infectious Disease Society of America
Subscribe To Our Newsletter & Stay Updated